6505--NUCLEAR MEDICINE RADIOPHARMACEUTICALS
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NETWORK CONTRACT OFFICE 19 (36C259)
Contract Value
Not provided
Codes & Classification
Solicitation Number
36C25926R0074
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
Documents4
The Department of Veterans Affairs, through its Network Contract Office 19 (NCO 19), has issued a Combined Synopsis/Solicitation for the procurement of nuclear medicine radiopharmaceuticals. This opportunity, identified by procurement number 36C25926R0074, is currently active and seeks to engage qualified contractors capable of supplying specialized radiopharmaceutical products essential for nuclear medicine applications within the VA healthcare system.
The primary objective of this procurement is to ensure a reliable and consistent supply of radiopharmaceuticals, which are critical for diagnostic and therapeutic procedures in nuclear medicine. The scope of work likely encompasses the manufacturing, packaging, and timely delivery of these pharmaceutical preparations, adhering to stringent quality and safety standards required for use in a clinical setting. Contractors are expected to demonstrate the capability to meet the unique handling, storage, and transportation requirements associated with radioactive materials, ensuring compliance with all applicable federal regulations.
This solicitation falls under the North American Industry Classification System (NAICS) code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and is further classified under Product Service Code (PSC) 6505, indicating a focus on drugs and biologicals. The procurement is managed by the federal contracting office of the Department of Veterans Affairs, specifically NCO 19, which serves a network of VA medical facilities.
Interested vendors should note that the solicitation is posted on SAM.gov, with four attachments available for review, which may contain detailed specifications, terms, and submission instructions. The primary point of contact for this opportunity is Barron Long, who can be reached via email at [email protected] or by phone at 303-712-5741 for any inquiries related to the solicitation.
The notice was posted on May 14, 2026, with a response deadline of May 18, 2026, providing a limited window for proposal submission. Contractors considering this opportunity should ensure they have the necessary certifications, experience in pharmaceutical manufacturing—particularly with radiopharmaceuticals—and the logistical infrastructure to support the VA’s requirements.
No specific set-aside requirements or special considerations are indicated in the provided information. However, as with all federal procurements, compliance with applicable VA and federal acquisition regulations is expected throughout the contract lifecycle.
This procurement represents a significant opportunity for qualified pharmaceutical manufacturers specializing in nuclear medicine products to support the healthcare needs of veterans by ensuring the availability of high-quality radiopharmaceuticals across the VA network.